Episode 10 – Patient conversations part three: the patient perspective
01 września 2025
In the tenth episode of the 12-part Illuminoz podcast series, Bianca Stadler speaks with Ellen Tutton – a person living with relapsing-remitting MS since 2015 – about what makes treatment conversations meaningful and empowering from the patient’s point of view.
What matters most when choosing or switching treatment? What barriers can stand in the way of access? And how can healthcare professionals tailor their communication to meet patients where they are?
Ellen shares her personal journey, advocacy insights, and practical advice for building trust and supporting informed, individualized care.
Informacje o podcaście:
“Illuminoz talks 2025” podcast series:
Episode 12 – PML: what is it, and why is it relevant in MS?
dr Tobias Bopp,
Episode 11 – Introducing biosimilar natalizumab
dr Heinz Wiendl,
Episode 9 – Patient conversations part two: the nurse perspective
karolinamalicka,
Episode 8 – Patient conversations part one: the neurologist perspective
dr Agne Straukiene,
Episode 7 – Lessons learned part two: the value of biosimilars in rheumatology
prof. Paul Emery,
Episode 6 – Lessons learned part one: the value of biosimilars in oncology
prof. Kai Hübel,
Episode 5 – Biosimilars and MS: improving access to high-efficacy treatment
dr Barbara Kornek,
Episode 4 – Treatment paradigms in MS: right patient, right treatment, right time
dr Laura Airas,
Episode 3 – MS treatment landscape part two: potential role of biosimilars
dr David Paling,
Episode 2 – MS treatment landscape part one: unmet needs
dr Luisa Klotz,
Episode 1 – Biosimilars: what are they, and why might they be important for MS?
dr Wallace Brownlee,
